Osvaldo Arén Frontera
Brigham and Women's Hospital
2 papers in the Anchorcite directory, published between 2015 and 2018, cited 13,308 times in total.
Research topics
- Cancer Immunotherapy and Biomarkers · 2 papers
- Lung Cancer Diagnosis and Treatment · 1 paper
- Lung Cancer Treatments and Mutations · 1 paper
- Renal cell carcinoma treatment · 1 paper
- Ferroptosis and cancer prognosis · 1 paper
Frequent co-authors
- Julie Renee Brahmer · 1 paper
- Karen L. Reckamp · 1 paper
- Lucio Crinò · 1 paper
- Wilfried Eberhardt · 1 paper
- Elena V Poddubskaya · 1 paper
- Scott Joseph Antonia · 1 paper
- Adam Płużański · 1 paper
- Everett E. Vokes · 1 paper
Papers
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung CancerNew England Journal of Medicine · 2015 · 8,551 citations
BACKGROUND: Patients with advanced squamous-cell non-small-cell lung cancer (NSCLC) who have disease progression during or after first-line chemotherapy have limited treatment options. This randomized, open-label, international, phase 3 study evaluated the efficacy and safety of nivolumab, a fully human IgG4…
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2018 · 4,757 citations
BACKGROUND: Nivolumab plus ipilimumab produced objective responses in patients with advanced renal-cell carcinoma in a pilot study. This phase 3 trial compared nivolumab plus ipilimumab with sunitinib for previously untreated clear-cell advanced renal-cell carcinoma. METHODS: We randomly assigned adults in…
Metadata from OpenAlex (CC0).